Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia
Public ClinicalTrials.gov record NCT00313885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of SR46349B (1 and 5mg/Day) Administered During 8 Weeks in Patients With Sleep Disorders in Fibromyalgia: Multi-center, Randomized, Double-blind, Placebo-controlled Study.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Fibromyalgics frequently report sleep disturbances, in particular poor and unrefreshing sleep. Additionally, studies have reported that sleep problems, pain and mood disturbances are associated in patients with fibromyalgia. By improving the quality of sleep, complaints of poor and unrefreshing sleep, fatigue, pain, which are among the main components of this chronic pain disorder may be improved.
Study identification
- NCT ID
- NCT00313885
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 205 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2004
- Primary completion
- May 31, 2005
- Completion
- May 31, 2005
- Last update posted
- Nov 29, 2010
2004 – 2005
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research | Phoenix | Arizona | 85013 | — |
| San Diego Arthritis Medical Clinic | San Diego | California | 92108 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Miami Research Assoc., Inc. | Miami | Florida | 33173 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Comprehensive Neuroscience | Atlanta | Georgia | 30328 | — |
| Physicians Research Group | Indianapolis | Indiana | 46250 | — |
| Wichita Clinic PA | Wichita | Kansas | 67208 | — |
| Westroads Medical Group | Omaha | Nebraska | 68114 | — |
| Physicians Research Options | Ogden | Utah | 84403 | — |
| Seattle Rheumatology Assoc. | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00313885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 29, 2010 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00313885 live on ClinicalTrials.gov.